ARCHIVES

ODAC Advice: Avoid ESAs In Curative Settings, Require Patients To Sign Informed Consent.

This article is from The Cancer Letter archive.

Vol. 34 No. 10 | March 14, 2008

Download PDF Visit The Full Archive

Related Articles

Hammer Says He’ll Demand Construction Funds If Data Supports The Need

August 12, 1983

In Brief: Muggia Leaving NCI For NYU In September; Seminar Planned On radiation Exposures

April 20, 1979

In Brief: ACCC Celebrates 25th: James Hospital Receives Large Donations

April 9, 1999

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006